Issued Patents All Time
Showing 1–25 of 89 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9458463 | Method for treatment of diabetes by a small molecule inhibitor for GRK5 | Mathias Falcenberg | 2016-10-04 |
| 9206130 | Quinoline derivatives as AXL kinase inhibitors | Pjotr Knyazev, Yixiang Zhang, Kéri György, Laszlo Orfi, Istvan Szabadkai | 2015-12-08 |
| 9011851 | Inhibitors of her3 activity | Edward Htun-Van Der Horst | 2015-04-21 |
| 8999982 | Pharmaceutically active compounds as Axl inhibitors | Carsten Schultz-Fademrecht, Bert Klebl, Axel Choidas, Uwe Koch, Jan Eickhoff +1 more | 2015-04-07 |
| 8685971 | Quinolinyloxyphenylsulfonamides | Robert Torka, Yixiang Zhang, György Kéri, László Örfi, István Szabadkai | 2014-04-01 |
| 8591903 | Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation | Andreas GSCHWIND, Stefan Hart | 2013-11-26 |
| 8557768 | Human nerve growth factor by recombinant technology | Alane M. Gray | 2013-10-15 |
| 8277802 | Diagnosis and prevention of cancer cell invasion | Pjotr Knyazev, Tatjana Knyazeva, Yuri Cheburkin, Peter Vajkoczy | 2012-10-02 |
| 8043806 | Method of diagnosing an RTK-hyperfunction induced disorder | Johannes Bange, Pjotr Knyazev | 2011-10-25 |
| 7964399 | Cell line comprising vector encoding truncated FLK-1 receptor | Werner Risau, Birgit Millauer, Aviv Gazit, Alex Levitzki | 2011-06-21 |
| 7678372 | Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer | Johannes Bange, Pjotr Knyazev | 2010-03-16 |
| 7632645 | EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF | Norbert Prezel, Esther Zwick-Wallasch, Henrik Daub | 2009-12-15 |
| 7531304 | Method for screening FGFR-4 agonists | Johannes Bange | 2009-05-12 |
| 7524495 | Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation | Andreas GSCHWIND, Stefan Hart | 2009-04-28 |
| 7371828 | Extracellular signal-regulated kinase sequences and methods of production and use | Cornelia Lechner, Niels Peter Hundahl Moller | 2008-05-13 |
| 7297774 | Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer | Johannes Bange, Pjotr Knyazev | 2007-11-20 |
| RE39355 | Preparation of human IGF via recombinant DNA technology | James Lee | 2006-10-17 |
| 7074589 | Nucleic acids encoding BDP-1 | Naohito Aoki, Yeong Woong Kim, Hong Wang, Zhengjun Chen, Oliver Nayler +1 more | 2006-07-11 |
| 7056508 | Receptor-type phosphotyrosine phosphatase-kappa antibodies | Joseph Schlessinger, Jan M. Sap, Wolfgang Vogel, Miriam Fuchs | 2006-06-06 |
| 7037677 | Megakaryocytic protein tyrosine kinase I | Mikhail Gishizky, Irmingard Sures | 2006-05-02 |
| 7034112 | Methods for diagnosis and treatment of MDK1 signal transduction disorders | Thomas Ciossek, Birgit Millauer | 2006-04-25 |
| 6913894 | Antibodies directed against signal regulator proteins | Hans-Jorg Buhring, Zhengjun Chen, Charles Cant | 2005-07-05 |
| 6908984 | Megakaryocytic protein tyrosine kinase I | Mikhail Gishizky, Irmingard Sures | 2005-06-21 |
| 6897029 | MCK-10 a novel receptor tyrosine kinase | Frauke Alves | 2005-05-24 |
| 6872699 | Truncated Flk-1 receptor protein, methods of use and a recombinant vector containing a nucleotide encoding the truncated Flk-1 protein | Werner Risau, Birgit Millauer, Aviv Gazit, Alex Levitzki | 2005-03-29 |